Results 141 to 150 of about 1,221,411 (264)

Cord blood red cell concentrates for preterm neonate transfusion: Insights from the multicenter BORN trial

open access: yesTransfusion, EarlyView.
Abstract Background The BORN trial suggested that using cord blood‐red blood cells (CB‐RBCs) to transfuse severely preterm neonates significantly improves clinical outcomes compared to standard adult donor RBCs (A‐RBC). Study Design and Methods The study illustrates CB‐RBC concentrate production and inventory management across nine CB banks ...
Claudio Pellegrino   +38 more
wiley   +1 more source

Hepatitis B virus in silvery gibbons (Hylobates moloch)

open access: yes, 2004
This research investigated a number of issues regarding hepatitis B virus (HBV) in the silvery gibbon (Hylobates moloch). Due to the relatively recent discovery of the virus in nonhuman primate populations, specific knowledge of the biological behaviour ...
Payne, Karen Louise
core  

血清中乙型肝炎病毒脱氧核糖核酸的检测

open access: yesZhongshan Daxue xuebao. Yixue kexue ban, 1984
乙型肝炎病毒(HBV)是属于嗜肝DNA病毒(Hepadna)的一种,完整病毒颗粒(Dane颗粒)的核心部分,含有双股环状脱氧核糖核酸(DNA),近年来对HBV DNA的研究取得迅速发展,HBV DNA克隆成功,而且可以用切口翻译方法把32P标记上克隆的HBV DNA,把它作为探针与血清中提取的DNA杂交,检测血清标本中是否存在HBV DNA,提供一种极为灵敏的检测血清中HBV的方法,我们开展了这个检测项目,应用斑点杂交试验直接检查血清标本的HBV DNA。
郑锡澄
doaj  

Residual risk of human immunodeficiency virus, hepatitis C, and hepatitis B following implementation of sexual risk behavior‐based screening in Canada

open access: yesTransfusion, EarlyView.
Abstract Background In 2022, Canadian Blood Services implemented a gender‐neutral sexual behavior‐based screening (SBBS) approach to donor deferral, replacing time‐based criteria targeting gay, bisexual and other men who have sex with men (gbMSM) and female partners of gbMSM. We assessed the impact of this policy change on human immunodeficiency virus (
Chinchin Wang   +3 more
wiley   +1 more source

HBV-DNA and Primary Immune Complex Glomerulonephritis [PDF]

open access: yesNephron, 2008
G, Rostoker   +7 more
openaire   +2 more sources

From Diagnosis to Durability: A Review of the European Bulevirtide Experience and Practical Learnings for CHD Management

open access: yesLiver International, Volume 46, Issue 8, August 2026.
ABSTRACT Hepatitis delta virus (HDV) infection causes chronic hepatitis D (CHD), the most severe form of chronic viral hepatitis with a high risk of progression to advanced liver disease. Off‐label pegylated interferon alpha was the primary treatment option in Europe prior to the introduction of bulevirtide, a first‐in‐class HDV entry inhibitor.
Monica Radu   +11 more
wiley   +1 more source

First Reported Case of Fulminant Weil's Disease in South Khorasan, Eastern Iran: Diagnostic Challenges in a Non‐Endemic Region and Implications for Military Deployment

open access: yesClinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Weil's disease should be considered even in non‐endemic regions when compatible clinical findings are accompanied by relevant exposure history. This case is epidemiologically notable as the first documented report from South Khorasan Province, highlighting the diagnostic challenges of leptospirosis in non‐endemic settings and the potential ...
Zohreh Azarkar   +3 more
wiley   +1 more source

Li-Reactive-Water-Group/BioRT-HBV: V-1.0 BioRT-HBV

open access: yes
HBV-BioRT is a reactive transport module that works with the semi-distributed rainfall-runoff model HBV ...
Kerins, Devon   +7 more
core   +1 more source

HBV-DNA [PDF]

open access: yes, 2019
openaire   +1 more source

Intratumoral Microbiota in Tumor: Current Understandings and Future Perspectives

open access: yesMedComm, Volume 7, Issue 7, July 2026.
Intratumoral bacteria are emerging as active regulators of cancer evolution rather than bystanders. This review outlines how tumor‐resident microbes drive tumor initiation and growth by inducing genomic instability, epigenetic reprogramming, oncogenic signaling, and chronic inflammation, while promoting metastatic spread via invasion, angiogenesis ...
Jiawei Chen   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy